Colloidal Silver Versus Antibiotic-Resistant CRE Bacteria
The Centers for Disease Control (CDC) is now warning that Carbapenem-Resistant Enterobacteriaceae (CRE) – which include drug-resistant forms of Klebsiella pneumonia and E. coli – are becoming “increasingly resistant” to antibiotic drugs.
“CRE are nightmare bacteria. Our strongest antibiotics don’t work and patients are left with potentially untreatable infections,” says CDC Director Tom Frieden, M.D., M.P.H.
Thankfully, preliminary research has demonstrated that colloidal silver and other forms of antimicrobial silver are astonishingly effective against these pathogens. Here’s what you need to know…
Hi, Steve Barwick here, for www.TheSilverEdge.com...
The Centers for Disease Control (CDC) is now calling for the entire U.S. health care community to work urgently – individually, regionally and nationally – to protect patients against infection by the new Carbapenem-Resistant Enterobacteriaceae (CRE) pathogens.
These lethal, drug-resistant pathogens are now spreading throughout hospital environments nationwide (and worldwide), killing up to 50% of all patients who end up with blood-borne infections.
According to the most recent CDC bulletin:
The New York Times also chimed in on the issue, warning in this news article:
Stay Out of Hospitals
Of course, the smartest thing to do in order to avoid becoming infected by this deadly group of pathogens is to stay the heck out of hospitals, where they are chiefly spread on the hands and gowns of hospital workers.
But if a hospital stay is unavoidable, colloidal silver may well be your one big hope of survival.
Indeed, if a hospital stay is in your near future, you might want to review my previous article titled “Colloidal Silver and Hospital-Acquired Infections: What You Can Do to Protect Yourself!”
And you might also want to review my previous article “Colloidal Silver and Airborne MRSA Pathogens” which discusses the “Cool Mist Vaporizer” trick for keeping hospital rooms (and homes) antiseptically clean using colloidal silver.
I warned of the spread of CRE pathogens way back in May, 2011, well before most health authorities were aware of this class of pathogens.
Back then, doctors thought there was only one form, which they had dubbed “CRKP,” which stands for Carbapenem-Resistant Klebsiella pneumonia. (Carbapenem, of course, is the so-called “antibiotic drug of last resort.)
Today, doctors are aware that other bacteria of the Enterobacteriaceae family have joined the ranks Carbapenem-resistant pathogens, including some forms of E. coli, as mentioned earlier.
So they have now changed the name from “CRKP” to the more inclusive “CRE,” which stands for Carbapenem-Resistant Enterobacteriaceae.
Silver’s Effectiveness Against Klebsiella
As I explained in my previous article, “Colloidal Silver and the Deadly Super-pathogen CRPK,” preliminary lab research indicates colloidal silver is astonishingly effective against the Klebsiella pneumonia pathogen.
In fact, up to 75% of antibiotic-resistant strains of the Klebsiella pathogen were stopped cold by silver-based antimicrobials.
And even when silver didn’t kill the pathogen, it completely disabled it, preventing it from becoming infectious.
According to the Physicians Guide to Natural Health Products that Work, by James Howenstine, M.D., colloidal silver has indeed been demonstrated to be effective against the Klebsiella pathogen:
And according to a nurse who posted to the internet about her experience after contracting CRKP:
“For me colloidal silver was a life saver when I contracted a serious form of pneumonia from the CRKP bacteria, or Carbepenem-resistant Klebsiella pneumonia, after taking care of two patients who were suspected of having it.”
The nurse went on to explain that she used a medical nebulizer to inhale the colloidal silver into her lungs, and thus get it into the bloodstream. (To learn how to use colloidal silver with a nebulizer, see the article at the link.)
And according to a May, 1999 report from the Microbiology Department of Brigham Young University in Provo, Utah, when colloidal silver was tested against Klebsellia pneumonia, it took only 2.5 ppm to “inhibit and kill” the pathogen!
Here’s an excerpt from the report, written by David A. Revilli, microbiologist, and Dr. Ron W. Leavitt, Ph.D., Professor of Microbiology/Molecular Biology, both of BYU:
Klebsiella pneumoniae (lower respiratory tract infections, nosocomial infections (infections spread in hospitals), urinary tract and wound infections, and bacteremia) inhibited and killed @ 2.5 ppm. 1/28/99 BYU Report.
So the good news is that colloidal silver appears to be extremely effective against at least one of the two Enterobacteriaceae family pathogens that are now causing such consternation among Centers for Disease Control medical bureaucrats.
And while this does not prove colloidal silver will be effective against the latest Carbapenem-resistant strains, it is certainly a strong enough indication for medical authorities to follow through on.
More importantly, it’s a strong enough indication for you to keep in the back of your mind, should you or a family member ever become infected with this particularly deadly class of pathogens.
Silver’s Effectiveness Against E. Coli
What’s more, the same types of past clinical results pretty much holds true for the second Enterobacteriaceae pathogen now causing fits among doctors and health authorities, i.e., the drug-resistant forms of E. coli.
In fact, back in June 2011 when a deadly, drug-resistant strain of the E. coli microbe was sweeping across Europe, I wrote an article titled “Colloidal Silver and E. Coli,” in which I revealed that silver-based antimicrobials had indeed been demonstrated to be effective against drug-resistant forms of the pathogen.
In that article, I revealed the seven clinical studies that have demonstrated the effectiveness of silver-based products – including silver ions, silver nanoparticles and colloidal silver -- against E. coli.
That included this study titled “Colloidal Silver as a New Antimicrobial Agent,” which was published in the International Journal of Microbiological Research back in 2010.
The study authors concluded that colloidal silver exhibited “powerful antimicrobial activity” against multi-drug resistant pathogens including E. coli, Staphylococcus aureus, Pseudomonas aregnosa and Salmonella typhi.
And in this study, titled “Bactericidal Effect of Silver Nanoparticles Against Multi-Drug Resistant Bacteria,” which was published in 2010 in the World Journal of Microbiology and Biotechnology, researchers found that the silver nanoparticles easily inactivated drug-resistant bacteria, including E. coli.
The researchers found that the tiny silver particles actually began inhibiting the bacterial growth rate from the very first moment of contact between the bacteria and the silver nanoparticles.
Finally, in another study, titled “Antimicrobial Activity of Colloidal Silver Nanoparticles Prepared by Sol-Gel Method,” published in 2011 in the Digest Journal of Nanomaterials and Biostructures, it was reported that “all tested microorganisms were completely inhibited at the concentration of 2–4 μg/ml of nano silver.”
This study included both the E. coli pathogen and the Klebsiella pneumoniae pathogen, which were killed in the laboratory at 3 ppm and 4 ppm colloidal silver, respectively!
So there you have it.
The preliminary evidence, based upon numerous past clinical studies, is that colloidal silver has been demonstrated to be astonishingly effective against drug-resistant strains of both Klebsiella pneumoniae and E. coli.
These are the two Enterobacteriaceae family pathogens that are now giving doctors fits worldwide, and causing the deaths of up to 50% of all who end up with blood borne infections.
Therefore, colloidal silver may well turn out to be one of the last lines of defense against the new “CRE” strains of these two pathogens the health authorities are now fighting against.
Of course, it remains to be seen if medical science picks up on this vital information on silver’s efficacy against drug-resistant strains of these two pathogens, and follows through on it.
Oftentimes, brewing crises like this one seem to be motivated more by pocketbook issues. In other words, scare stories like this one are often used to justify why the big drug companies should be paid hundreds of millions of dollars in taxpayer monies to develop new antibiotic drugs.
(See my article “Big Pharma Shuns Silver; Blackmails U.S. Government Into Paying for New Antibiotic Drugs With Taxpayer Money” if you’d like to know more about the scam of using taxpayer money to pay for new antibiotic drug development.)
Nevertheless, it’s important for you to have this crucial information on silver’s efficacy against drug-resistant pathogens.
After all, you never know when it may come in handy, if only to pass along to your own physician should you or a loved one end up with a similar hospital-acquired infection!
I’ll be back next week with another great article on colloidal silver.
Meanwhile, if you’re interested in learning how to make your own high-quality colloidal silver – in the comfort and privacy of your own home, for less than 36 cents a quart – just click the link in this sentence.
Yours for the safe, sane and responsible use of colloidal silver,
Steve Barwick, author
Important Note and Disclaimer: The contents of this Ezine have not been evaluated by the Food and Drug Administration. Information conveyed herein is from sources deemed to be accurate and reliable, but no guarantee can be made in regards to the accuracy and reliability thereof. The author, Steve Barwick, is a natural health journalist with over 30 years of experience writing professionally about natural health topics. He is not a doctor. Therefore, nothing stated in this Ezine should be construed as prescriptive in nature, nor is any part of this Ezine meant to be considered a substitute for professional medical advice. Nothing reported herein is intended to diagnose, treat, cure or prevent any disease. The author is simply reporting in journalistic fashion what he has learned during the past 17 years of journalistic research into colloidal silver and its usage. Therefore, the information and data presented should be considered for informational purposes only, and approached with caution. Readers should verify for themselves, and to their own satisfaction, from other knowledgeable sources such as their doctor, the accuracy and reliability of all reports, ideas, conclusions, comments and opinions stated herein. All important health care decisions should be made under the guidance and direction of a legitimate, knowledgeable and experienced health care professional. Readers are solely responsible for their choices. The author and publisher disclaim responsibility and/or liability for any loss or hardship that may be incurred as a result of the use or application of any information included in this Ezine.
Copyright 2013 | Life & Health Research Group, LLC | PO Box 1239 | Peoria AZ 85380-1239 | All rights reserved